Dr. Lindsey Berkson

2-MEO, or 2-methoxyestradiol, is a final metabolite of estrogen. It is Nature’s intention to utilize this final metabolite for a number of protective physiologic functions. 

You will learn physiologic actions of 2-MEO such as anti-inflammatory, anti-apoptotic, anti-angiogenic, anti-mutagenic, anti-carcinogenic, and more. This means that this end metabolite of estrogen makes sense physiologically for conditions from Rheumatoid Arthritis to cancer, as adjunctive care. 

Nature never does anything without a good reason. Since many estrogen signals are “growth promoters” this final metabolite is a “growth controller”, making estrogen metabolism a safe full circle.

Thus, 2-MEO has been looked at in peer review literature as a powerful adjunctive care for diverse cancers from breast to osteosarcoma. You even hears some case reports. 

We go through peer review studies demonstrating 2-MEO's use for specific cancers, dosages, contraindications and more.